Prefilled syringes are disposable syringes,
filled with a fixed quantity of therapeutic drug. The syringes are designed to
administer the accurate amount of dosage for reducing the wastage of
medication. These are novel devices used for delivering drugs with improved
affordability, accuracy, efficacy, convenience, safety, sterility, and
accessibility. The syringes are used in treatment of diabetes, anaphylaxis,
rheumatoid arthritis, and other diseases, such as multiple sclerosis, psoriasis
and anemia.
According to study, “Global
Prefilled syringes Market Size study, by material (glass-based and plastic
based) type (safety prefilled syringes and conventional prefilled syringes)
Design (single-chamber prefilled syringes, dual-chamber prefilled syringes and
customized prefilled syringes) and Regional Forecasts 2018-2025” the
key companies operating in the global prefilled syringes market are
Gerresheimer AG, Becton, Dickinson and Company, Abbott Laboratories, Schott AG,
Terumo Medical Corporation, Cardinal Health, Inc., Scandinavian Health Limited
(SHL Group), Unilife Corporation, Vetter Pharma International GmbH, West
Pharmaceutical Services, Inc., Baxter International, Catalent, Inc., Stevanato
Group, Weigao Group, Nipro Corporation, OMPI, Medpro Inc.
Based on type, prefilled syringes market is
segmented into safety prefilled syringes and conventional prefilled syringes.
Based on material, market is segmented into plastic syringes and glass
prefilled syringes (baked on silicone syringes and oil siliconised syringes).
Plastic prefilled syringes holds major share in market owing to increase in
awareness among healthcare practitioners and physicians to decrease medication
errors. Based on design type, market is segmented into single-chamber prefilled
syringes, dual-chamber prefilled syringes and customized prefilled syringes.
Single-chamber prefilled syringes segment provides safety and simplifies needle
stick protection. Based on therapeutic, market is segmented into small
molecules and large molecules. Based on application, market is segmented into
rheumatoid arthritis, anaphylaxis, diabetes, and others (multiple sclerosis,
cancer, and others). In addition, based on end-user, market is segmented into
ambulatory surgical center, mail order pharmacies and hospitals or clinics.
The prefilled syringes market is driven by
rise in incidence rate of chronic disease, followed by growth in home-based
healthcare market, increase in adoption of self-injection devices such as pen
injectors, growth in technological advancement, appropriate reimbursement
policies, increase in advancement in biopharmaceutical industry, rise in demand
for efficient & easy-to-use drug delivery devices and increase in benefits
of using prefilled syringes over conventional vials. However, stringent government
regulations, product recalls and availability of alternate drug-delivery
methods may impact the market. Moreover, increase in demand for injectable
drugs in prefilled forms and rise in demand for biologics & bio-similars
are key opportunities for market. Furthermore, rise in adoption of ready-to-use
elastomeric & customized syringe components by drug manufacturers is major
trend of market.
Based on geography, the North-American and
European regions hold major share in prefilled syringe market owing to constant
increase in geriatric population, rise in trend of home-based treatment as well
as high healthcare expenditure and increase in demand for quality healthcare in
the regions. The Asian-Pacific region is expected to emerge as the fastest
growing region due to increase in number of clinics & hospitals and
improvement in healthcare infrastructure over the forecast period. It is
anticipated that the market will be reached at US $9.3 billion by 2025.
For more information, click on the
link below:
Contact Us:
Ken Research
Ankur Gupta, Head Marketing &
Communications
+91
9015378249